Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Rambam Health Care Campus |
---|---|
Information provided by: | Rambam Health Care Campus |
ClinicalTrials.gov Identifier: | NCT00305149 |
Condition | Intervention |
---|---|
Classical Hodgkin Lymphoma Nodular Sclerosis Mixed Cellularity Lymphocyte Depletion Lymphocyte Rich |
Procedure: interim therapy scintigraphy study gallium scan or PET/CT Procedure: "interim gallium or PET/CT" |
Study Type: | Interventional |
Study Design: | Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Use of Risk Factors for Initiation Therapy With Beacopp or Escalated Beacopp and Interim Evaluation and Modification of Therapy Based on Scintigraphy Results. |
Estimated Enrollment: | 130 |
Study Start Date: | July 1999 |
Estimated Study Completion Date: | December 2005 |
Patients were eligible if they had early unfavorable disease or patients who presented with stage III or IV disease .Pt assigned to receive 6 cycles of Bleomycin Etoposide, Doxorubicin, Cyclophosphamide Procarbazine, Prednisone (BEACOPP) or increased dose BEACOPP. (IDB). Patient with Stage I or II with ³4 sites of disease, age
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
-
Study ID Numbers: | riskadapted beacopp/CTIL |
Study First Received: | March 20, 2006 |
Last Updated: | March 20, 2006 |
ClinicalTrials.gov Identifier: | NCT00305149 History of Changes |
Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
Hodgkin Lymphoma BEACOPP PET Gallium Tailored therapy |
Lymphatic Diseases Immunoproliferative Disorders Hodgkin Lymphoma, Adult Hodgkin's Disease |
Sclerosis Lymphoproliferative Disorders Hodgkin Disease Lymphoma |
Lymphatic Diseases Neoplasms Pathologic Processes Immunoproliferative Disorders Neoplasms by Histologic Type |
Immune System Diseases Sclerosis Lymphoproliferative Disorders Lymphoma Hodgkin Disease |